© 2001 by European Society of Cardiology
Copyright © 2001, European Society of Cardiology
Experimental evaluation of coronary collateral development
Division of Clinical Trial Design and Analysis, Office of Therapeutics Research and Review, Center for Biologics Evaluation and Research, U.S. Food and Drug Administration, Rockville, MD 20852-1428, USA
* Tel.: +1-301-827-5350; fax: +1-301-827-5394 ungere{at}cber.fda.gov
During the last decade, there has been great interest in the potential use of biologic agents and mechanical techniques to enhance myocardial collateral development. Available experimental methods to detect the effects of interventions designed to improve collateral function include assessment of vascular cell proliferation, quantification of vessel number and size, appraisal of myocardial perfusion, and evaluation of myocardial function. The purpose of this review is to discuss the various experimental approaches for the evaluation of coronary collateral development, highlighting the relative strengths and limitations of the commonly used animal models and methods of assessment.
KEYWORDS Blood flow; Collateral circulation; Coronary circulation; Microcirculation; Regional blood flow
* The opinions expressed are those of the author, and not necessarily those of the U.S. Food and Drug Administration.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  B. G. Leshnower, H. Sakamoto, H. Hamamoto, A. Zeeshan, J. H. Gorman III, and R. C. Gorman Progression of myocardial injury during coronary occlusion in the collateral-deficient heart: a non-wavefront phenomenon Am J Physiol Heart Circ Physiol, September 1, 2007; 293(3): H1799 - H1804. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Bondke, P. Hillmeister, and I. R. Buschmann Exact Assessment of Perfusion and Collateral Vessel Proliferation in Small Animal Models Circ. Res., April 27, 2007; 100(8): e82 - e83. [Full Text] [PDF]
|
|
|
|
 |
|
 R. W. Seidler, M. C. Lenter, B. D. Guth, and H. Doods Short-Term Intra-Arterial Infusion of Monocyte Chemoattractant Protein-1 Results in Sustained Collateral Artery Growth Journal of Cardiovascular Pharmacology and Therapeutics, March 1, 2007; 12(1): 61 - 68. [Abstract] [PDF]
|
|
|
|
|
|
I. Eitenmuller, O. Volger, A. Kluge, K. Troidl, M. Barancik, W.-J. Cai, M. Heil, F. Pipp, S. Fischer, A. J.G. Horrevoets, et al. The Range of Adaptation by Collateral Vessels After Femoral Artery Occlusion Circ. Res., September 15, 2006; 99(6): 656 - 662. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Toyota, D. C. Warltier, T. Brock, E. Ritman, C. Kolz, P. O'Malley, P. Rocic, M. Focardi, and W. M. Chilian Vascular Endothelial Growth Factor Is Required for Coronary Collateral Growth in the Rat Circulation, October 4, 2005; 112(14): 2108 - 2113. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. E. Hoefer, S. Grundmann, S. Schirmer, N. van Royen, B. Meder, C. Bode, J. J. Piek, and I. R. Buschmann Aspirin, But Not Clopidogrel, Reduces Collateral Conductance in a Rabbit Model of Femoral Artery Occlusion J. Am. Coll. Cardiol., September 20, 2005; 46(6): 994 - 1001. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Simons Angiogenesis: Where Do We Stand Now? Circulation, March 29, 2005; 111(12): 1556 - 1566. [Full Text] [PDF]
|
|
|
|
 |
|
 S. H. Schirmer, I. R. Buschmann, M. M. Jost, I. E. Hoefer, S. Grundmann, J.-P. Andert, S. Ulusans, C. Bode, J. J. Piek, and N. van Royen Differential effects of MCP-1 and leptin on collateral flow and arteriogenesis Cardiovasc Res, November 1, 2004; 64(2): 356 - 364. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. C. Hughes, M. J. Post, M. Simons, and B. H. Annex Translational Physiology: Porcine models of human coronary artery disease: implications for preclinical trials of therapeutic angiogenesis J Appl Physiol, May 1, 2003; 94(5): 1689 - 1701. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. E. Hoefer, N. van Royen, J. E. Rectenwald, E. J. Bray, Z. Abouhamze, L. L. Moldawer, M. Voskuil, J. J. Piek, I. R. Buschmann, and C. K. Ozaki Direct Evidence for Tumor Necrosis Factor-{alpha} Signaling in Arteriogenesis Circulation, April 9, 2002; 105(14): 1639 - 1641. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. C. Hughes, S. S. Biswas, B. Yin, D. V. Baklanov, B. H. Annex, R. E. Coleman, T. R. DeGrado, C. K. Landolfo, K. P. Landolfo, and J. E. Lowe A comparison of mechanical and laser transmyocardial revascularization for induction of angiogenesis and arteriogenesis in chronically ischemic myocardium J. Am. Coll. Cardiol., April 3, 2002; 39(7): 1220 - 1228. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. S. Kellar, L. K. Landeen, B. R. Shepherd, G. K. Naughton, A. Ratcliffe, and S. K. Williams Scaffold-Based Three-Dimensional Human Fibroblast Culture Provides a Structural Matrix That Supports Angiogenesis in Infarcted Heart Tissue Circulation, October 23, 2001; 104(17): 2063 - 2068. [Abstract] [Full Text] [PDF]
|
|